2/22/2026 at 7:00:27 PM
The process talks about removing trials that were performed in unhealthy populations, but expanding the top two entries shows almost exclusively trials performed in patients with Parkinson’s disease, Alzheimer’s, ADHD, and more. So take the AI-based filtering with a huge dose of skepticism.Nootropics communities like to wave these details away because they like positive results and think that the drugs simply increase cognition, but that’s rarely true.
The #2 entry in the list is the perfect example of this: Acetylcholinesterase inhibitors can show positive effects in disease states like Parkinson’s (where dopaminergic neurons are destroyed, resulting in specific imbalances) but they are known to induce depression in healthy volunteers. Confusingly, they can cause feelings of positive effect early on before the depression sets in for some people. This leads to an all too common scenario on nootropics forums where someone suffers from depression for months or years before realizing that their supplement stack containing cholinergic substances is making it worse. Some times people don’t realize this until they accidentally run out and start feeling better after a few days of not taking their supplements.
by Aurornis